FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092140613> ?p ?o ?g. }

• W2092140613 endingPage "466" @default.
• W2092140613 startingPage "458" @default.
• W2092140613 abstract "To evaluate the effects of treatment with fluticasone propionate vs placebo on bone, hypothalamic-pituitary-adrenal (HPA) axis function, and the eyes in patients with asthma.This randomized, double-blind, placebo-controlled study of 160 patients with asthma who had minimal previous exposure to corticosteroids was conducted from July 1994 through June 1997. Patients received fluticasone at 88 microg twice daily, fluticasone at 440 microg twice daily, or placebo twice daily for 2 years. Bone mineral density (BMD) was evaluated every 6 months by lumbar spine, proximal femur, and total body scans. Measurements of HPA axis function and ophthalmic evaluations were conducted at similar intervals.Among the 3 groups, no significant differences were observed in BMD at week 104 (at any anatomical site). Mean percent change from baseline in the lumbar spine was less than 1% for all 3 groups. At all time points, HPA axis function was similar in the 88-microg fluticasone group compared with the placebo group. For mean change from baseline in corticotropin-stimulated peak cortisol (P = .003 and P = .02 at weeks 24 and 52, respectively) and area under the stimulated plasma cortisol vs time curve (P = .002 and P = .02 at weeks 24 and 52, respectively), statistically significant reductions from baseline were observed in the 440-microg fluticasone group compared with the placebo group. These reductions of 10% to 13% from baseline were not accompanied by other signs of systemic effect and did not persist with continued treatment (at weeks 76 and 104). No important ocular changes were observed.Long-term treatment with 88 microg of fluticasone twice daily was comparable to placebo in all skeletal, ophthalmic, and HPA axis function assessments. Treatment with fluticasone at 440 microg twice daily resulted in no significant effects on BMD and a statistically significant but not clinically important temporary reduction in cortisol production." @default.
• W2092140613 created "2016-06-24" @default.
• W2092140613 creator A5003930087 @default.
• W2092140613 creator A5014280869 @default.
• W2092140613 creator A5036580346 @default.
• W2092140613 creator A5049851879 @default.
• W2092140613 creator A5051487319 @default.
• W2092140613 creator A5077485145 @default.
• W2092140613 creator A5079023447 @default.
• W2092140613 creator A5079974679 @default.
• W2092140613 date "2004-04-01" @default.
• W2092140613 modified "2023-10-14" @default.
• W2092140613 title "Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind, Placebo-Controlled Trial" @default.
• W2092140613 cites W1965459331 @default.
• W2092140613 cites W1972488771 @default.
• W2092140613 cites W1976788001 @default.
• W2092140613 cites W1977455487 @default.
• W2092140613 cites W1982682585 @default.
• W2092140613 cites W1992846913 @default.
• W2092140613 cites W1999194556 @default.
• W2092140613 cites W2000498293 @default.
• W2092140613 cites W2001564937 @default.
• W2092140613 cites W2002994755 @default.
• W2092140613 cites W2016224286 @default.
• W2092140613 cites W2031336337 @default.
• W2092140613 cites W2033830300 @default.
• W2092140613 cites W2034001398 @default.
• W2092140613 cites W2039000262 @default.
• W2092140613 cites W2040645421 @default.
• W2092140613 cites W2044912473 @default.
• W2092140613 cites W2045358685 @default.
• W2092140613 cites W2047563297 @default.
• W2092140613 cites W2061819610 @default.
• W2092140613 cites W2073347122 @default.
• W2092140613 cites W2083311965 @default.
• W2092140613 cites W2092941796 @default.
• W2092140613 cites W2093837558 @default.
• W2092140613 cites W2102765172 @default.
• W2092140613 cites W2108073684 @default.
• W2092140613 cites W2112102331 @default.
• W2092140613 cites W2136014948 @default.
• W2092140613 cites W2136224854 @default.
• W2092140613 cites W2148878442 @default.
• W2092140613 cites W2149383913 @default.
• W2092140613 cites W2158601360 @default.
• W2092140613 cites W2335475908 @default.
• W2092140613 cites W2338308982 @default.
• W2092140613 cites W4239927125 @default.
• W2092140613 doi "https://doi.org/10.4065/79.4.458" @default.
• W2092140613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15065610" @default.
• W2092140613 hasPublicationYear "2004" @default.
• W2092140613 type Work @default.
• W2092140613 sameAs 2092140613 @default.
• W2092140613 citedByCount "42" @default.
• W2092140613 countsByYear W20921406132012 @default.
• W2092140613 countsByYear W20921406132013 @default.
• W2092140613 countsByYear W20921406132014 @default.
• W2092140613 countsByYear W20921406132015 @default.
• W2092140613 countsByYear W20921406132018 @default.
• W2092140613 countsByYear W20921406132019 @default.
• W2092140613 countsByYear W20921406132020 @default.
• W2092140613 countsByYear W20921406132021 @default.
• W2092140613 countsByYear W20921406132022 @default.
• W2092140613 countsByYear W20921406132023 @default.
• W2092140613 crossrefType "journal-article" @default.
• W2092140613 hasAuthorship W2092140613A5003930087 @default.
• W2092140613 hasAuthorship W2092140613A5014280869 @default.
• W2092140613 hasAuthorship W2092140613A5036580346 @default.
• W2092140613 hasAuthorship W2092140613A5049851879 @default.
• W2092140613 hasAuthorship W2092140613A5051487319 @default.
• W2092140613 hasAuthorship W2092140613A5077485145 @default.
• W2092140613 hasAuthorship W2092140613A5079023447 @default.
• W2092140613 hasAuthorship W2092140613A5079974679 @default.
• W2092140613 hasConcept C126322002 @default.
• W2092140613 hasConcept C142724271 @default.
• W2092140613 hasConcept C168563851 @default.
• W2092140613 hasConcept C202061045 @default.
• W2092140613 hasConcept C204787440 @default.
• W2092140613 hasConcept C27081682 @default.
• W2092140613 hasConcept C2776042228 @default.
• W2092140613 hasConcept C2776541429 @default.
• W2092140613 hasConcept C2776804153 @default.
• W2092140613 hasConcept C2776886416 @default.
• W2092140613 hasConcept C2779028295 @default.
• W2092140613 hasConcept C2779329777 @default.
• W2092140613 hasConcept C2781212218 @default.
• W2092140613 hasConcept C2991744798 @default.
• W2092140613 hasConcept C42219234 @default.
• W2092140613 hasConcept C71924100 @default.
• W2092140613 hasConcept C90924648 @default.
• W2092140613 hasConceptScore W2092140613C126322002 @default.
• W2092140613 hasConceptScore W2092140613C142724271 @default.
• W2092140613 hasConceptScore W2092140613C168563851 @default.
• W2092140613 hasConceptScore W2092140613C202061045 @default.
• W2092140613 hasConceptScore W2092140613C204787440 @default.
• W2092140613 hasConceptScore W2092140613C27081682 @default.
• W2092140613 hasConceptScore W2092140613C2776042228 @default.
• W2092140613 hasConceptScore W2092140613C2776541429 @default.

• next